Immune-related adverse events predict the therapeutic efficacy of pembrolizumab in urothelial cancer patients

被引:19
|
作者
Kawai, Taketo [1 ]
Sato, Yusuke [1 ]
Makino, Katsuhiro [1 ]
Yamada, Yuta [1 ]
Nomiya, Akira [1 ]
Nakamura, Masaki [1 ]
Yamada, Daisuke [1 ]
Suzuki, Motofumi [1 ]
Igawa, Yasuhiko [1 ]
Kume, Haruki [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan
关键词
ASSOCIATION; NIVOLUMAB;
D O I
10.1016/j.ejca.2019.05.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:114 / 115
页数:2
相关论文
共 50 条
  • [21] Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review
    Kijima, Toshiki
    Fukushima, Hiroshi
    Kusuhara, Shota
    Tanaka, Hajime
    Yoshida, Soichiro
    Yokoyama, Minato
    Ishioka, Junichiro
    Matsuoka, Yoh
    Numao, Noboru
    Sakai, Yasuyuki
    Saito, Kazutaka
    Matsubara, Nobuaki
    Yuasa, Takeshi
    Masuda, Hitoshi
    Yonese, Junji
    Kageyama, Yukio
    Fujii, Yasuhisa
    [J]. CLINICAL GENITOURINARY CANCER, 2021, 19 (03) : 208 - +
  • [22] Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sanda, Gregory E.
    Shabto, Julie M.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Yantorni, Lauren B.
    Russler, Greta Anne
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Kissick, Haydn
    Ogan, Kenneth
    Master, Viraj A.
    Carthon, Bradley C.
    Kucuk, Omer
    Bilen, Mehmet Asim
    [J]. ONCOLOGIST, 2023, : 1072 - 1078
  • [23] Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases
    Huo, Cecilia W.
    Gunadasa, Indika
    Gkolia, Panagiota
    Shackleton, Mark
    Hunn, Martin
    [J]. MELANOMA RESEARCH, 2023, 33 (01) : 58 - 65
  • [24] Impact of Immune-related Adverse Events on Nivolumab Efficacy in Patients With Upper Gastrointestinal Cancer
    Booka, Eisuke
    Kikuchi, Hirotoshi
    Haneda, Ryoma
    Soneda, Wataru
    Kawata, Sanshiro
    Murakami, Tomohiro
    Matsumoto, Tomohiro
    Hiramatsu, Yoshihiro
    Takeuchi, Hiroya
    [J]. IN VIVO, 2021, 35 (04): : 2321 - 2326
  • [25] Immune dysregulation in cancer patients developing immune-related adverse events
    Shaheen Khan
    Saad A. Khan
    Xin Luo
    Farjana J. Fattah
    Jessica Saltarski
    Yvonne Gloria-McCutchen
    Rong Lu
    Yang Xie
    Quan Li
    Edward Wakeland
    David E. Gerber
    [J]. British Journal of Cancer, 2019, 120 : 63 - 68
  • [26] Immune dysregulation in cancer patients developing immune-related adverse events
    Khan, Shaheen
    Khan, Saad A.
    Luo, Xin
    Fattah, Farjana J.
    Saltarski, Jessica
    Gloria-McCutchen, Yvonne
    Lu, Rong
    Xie, Yang
    Li, Quan
    Wakeland, Edward
    Gerber, David E.
    [J]. BRITISH JOURNAL OF CANCER, 2019, 120 (01) : 63 - 68
  • [27] A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma
    Wang, Bengang
    Hao, Xiangjun
    Yan, Jinshan
    Li, Xin
    Zhao, Mingfang
    Han, Tao
    [J]. JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2024, 12 (03) : 225 - 243
  • [28] Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
    Yang, Ruoning
    Wang, Haiyang
    Yin, Xiaomeng
    Frey, Benjamin
    Gaipl, Udo S.
    Shi, Hubing
    Ma, Xuelei
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] A genomics model to predict immune-related adverse events in cancer patients treated with checkpoint inhibitors
    Scott, Emma C.
    Kazandjian, Dickran
    Santana-Quintero, Luis
    Ghazanchyan, Tigran
    Petrovskaya, Svetlana
    Zhang, Yong
    Rosenberg, Amy
    Rao, V. Ashutosh
    Marte, Jennifer L.
    Blumenthal, Gideon M.
    Theoret, Marc R.
    Pazdur, Richard
    Gulley, James L.
    Beaver, Julia A.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [30] Cutaneous immune-related adverse events predict longer patient survival in advanced cancer patients
    Lu, C.
    Zhang, S.
    Tang, K.
    Ugwu-Dike, P.
    Raval, N.
    Seo, J.
    Wan, G.
    Nguyen, N.
    Alexander, N.
    Jairath, R.
    Phillipps, J.
    Leung, B.
    Theodosakis, N.
    Zubiri, L.
    Boland, G.
    Liu, D.
    Chen, S.
    LeBoeuf, N.
    Reynolds, K.
    Yu, K.
    Tsao, H.
    Demehri, S.
    Gusev, A.
    Kwatra, S. G.
    Semenov, Y.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S36 - S36